Advanced IVF Treatments (IVF Add-ons) in Türkiye: Which Extras Really Improve Your Chances — and Which Don't
If you have started IVF, you have probably been handed a menu of optional extras — time-lapse imaging, embryo genetic testing, special culture fluids, an endometrial "scratch" — each presented as a way to finally bring home a baby. The hard truth that few clinics say plainly is that most of these add-ons are not backed by strong evidence, and none is currently rated as clearly effective for most patients. Working with Associate Professor Dr. Cengiz Andan, we take a different starting point: before adding paid extras, we look for treatable conditions that genuinely lower IVF success and can be corrected. This page explains, honestly, which advanced IVF treatments may help, which probably won't, and how we approach the decision in Türkiye.
At a glance
- What they are: IVF add-ons (advanced IVF treatments) are optional extra procedures, tests and medicines offered alongside standard IVF, often charged separately.
- The honest reality: most add-ons lack strong evidence of improving live birth, and at present none is rated as clearly effective for most patients.
- When some may help: a few add-ons are reasonable in specific situations, such as embryo genetic testing in selected older patients.
- Fix the body first: correcting a hydrosalpinx, submucosal fibroid, polyp or significant endometriosis can raise IVF success more than most add-ons.
- Starting from abroad: you can send your IVF history and imaging for a non-binding online second opinion before paying for any extra.
What are IVF add-ons (advanced IVF treatments) exactly?
IVF add-ons, often marketed as advanced IVF treatments, are optional extra procedures, tests or medicines used on top of standard IVF with the aim of improving the chance of success. They range from laboratory techniques such as time-lapse imaging to tests like genetic screening of embryos, special transfer fluids, and procedures on the womb lining. Many are offered as paid extras, and the number available has grown quickly — a national regulator currently lists around 13 reviewed add-ons. The challenge for patients is that demand and marketing have outpaced the evidence.
Do IVF add-ons actually work? The honest evidence
The honest answer is that most IVF add-ons are not supported by good-quality evidence that they increase live birth rates, and at present none is rated as clearly effective for most patients. A widely used regulator's rating system grades add-ons from "no evidence of benefit" through "conflicting evidence," and a recent review of around 13 add-ons found that none met the standard for a clear, proven benefit. This does not mean every add-on is useless for everyone — it means the burden of proof has not been met, so each should be a careful decision rather than a default. The table below summarizes how the most common ones are generally rated.
| Add-on | What it aims to do | Evidence rating (general) |
|---|---|---|
| Time-lapse imaging | Select the "best" embryo | No clear benefit |
| PGT-A (embryo screening) | Avoid abnormal embryos | No clear overall benefit |
| Endometrial scratch | Improve implantation | Conflicting / unclear |
| EmbryoGlue | Help embryo stick | Limited / uncertain |
| Immune treatments | Reduce rejection | No evidence / caution |
Source: Human Fertilisation and Embryology Authority (HFEA), add-ons rating system
Time-lapse imaging and incubation — is it worth paying for?
Time-lapse imaging continuously photographs embryos as they grow, in the hope of choosing the one most likely to implant, but current evidence does not show it improves live birth rates compared with standard incubation. If a clinic includes it at no extra charge as part of routine care, there is little reason to object. Paying a significant extra fee for it, however, is hard to justify on the evidence as it stands. The technology is appealing, but appeal is not the same as proof.
PGT-A (genetic testing of embryos) — who might genuinely benefit?
PGT-A screens embryos for the correct number of chromosomes before transfer, and while it is intuitively attractive, the evidence does not show it raises the overall chance of a baby for most patients. Its rationale is stronger with age, because the share of chromosomally abnormal embryos rises from roughly 30-40 % under the age of 35 to around 70-80 % over the age of 40. In selected older women or those with repeated miscarriage, PGT-A may reduce miscarriage and shorten time to pregnancy, even if cumulative live birth is not improved. It is a case-by-case discussion, not a routine extra.
Source: European Society of Human Reproduction and Embryology (ESHRE)
Assisted hatching and EmbryoGlue — what does the evidence show?
Assisted hatching thins the shell around the embryo and EmbryoGlue is a transfer fluid enriched with hyaluronic acid, both intended to help the embryo implant, yet the evidence for either improving live birth is limited and inconsistent. EmbryoGlue may offer a small benefit in some studies but the picture is far from settled. Assisted hatching has not shown a reliable advantage for most patients. Neither should be presented as a decisive step.
Endometrial scratch, ERA and receptivity tests — useful after failed transfers?
An endometrial scratch deliberately irritates the womb lining to make it more receptive, and tests such as ERA aim to time the transfer precisely, but neither has shown a clear, consistent benefit for most patients. The scratch is often discussed after repeated implantation failure, yet good studies have not demonstrated a reliable improvement. Receptivity and microbiome tests remain investigational for routine use. We may consider these only in carefully selected situations and explain the uncertainty honestly.
| Situation | Add-on sometimes considered | Honest note |
|---|---|---|
| Repeated implantation failure | Endometrial scratch / ERA | No clear proven benefit |
| Older age / recurrent miscarriage | PGT-A | May reduce miscarriage in some |
| Suspected lining infection | EMMA / ALICE tests | Investigational |
Source: National Institute for Health and Care Excellence (NICE), fertility guidance
Immune treatments (intralipids, IVIG, steroids) — a word of caution
Immune tests and treatments such as intralipids, intravenous immunoglobulin and steroids are offered on the theory that the body "rejects" an embryo, but they are largely rated as having no evidence of benefit and some carry real risks. These are among the add-ons where the gap between marketing and proof is widest. Because a few of them can cause genuine side effects, the potential harm is not only financial. We do not recommend them outside a specific, properly justified situation.
ICSI, IMSI and PICSI — the sperm-selection add-ons
ICSI, where a single sperm is injected into an egg, is a standard and valuable treatment for male-factor infertility rather than an optional extra, and it is used in a large share of cycles worldwide. Its more elaborate variations — IMSI, which magnifies sperm more highly, and PICSI, which selects sperm by binding — have not shown a reliable benefit over standard ICSI for most patients. They are reasonable to question if offered as paid upgrades. The core technique matters; the upgrades mostly do not.
Why fixing the body first beats most add-ons
For many couples, the single biggest improvement in IVF success comes not from a laboratory add-on but from correcting a condition in the pelvis that quietly lowers the odds. A hydrosalpinx — a fluid-filled, blocked tube — can roughly halve IVF success, reducing pregnancy rates by around 50 %, and removing or clipping it before treatment restores those odds. Submucosal fibroids, polyps, significant endometriosis (including deep or bowel endometriosis) and adenomyosis can all reduce implantation, and endometriosis is found in around 25-50 % of women with infertility. We treat the underlying condition first, because that is where minimally invasive surgery genuinely moves the numbers.
Source: American Society for Reproductive Medicine (ASRM)
How we approach advanced IVF treatments
Our approach rests on one principle: evidence before extras, and the patient's body before the laboratory. We assess every couple for treatable conditions, review prior cycles in detail, and recommend an add-on only when there is a sensible, honest reason for it in that specific case. We work in coordination with your IVF team rather than replacing it, focusing on the surgical and diagnostic side where we add the most value. As Associate Professor Dr. Cengiz Andan and our team, we would rather talk you out of an extra you do not need than sell you hope by the item.
Why surgical experience matters in fertility care
The part of fertility care where experience changes outcomes most is the accurate diagnosis and minimally invasive correction of conditions that lower IVF success. Associate Professor Dr. Cengiz Andan brings 18 years in practice, more than 2,000 laparoscopic procedures and over 500 endometriosis surgeries, with a complication rate of around 2 %. That depth matters when deciding whether a fibroid truly needs removing or whether a tube should be treated before IVF. Every procedure still carries some risk, and results vary from person to person, which we always state plainly.
Your home country or Türkiye — what's the real difference?
The honest answer is that the quality of IVF and the surgery around it can be very high in both your home country and Türkiye — the real differences lie in access and cost, not in standard. The same international guidelines and the same minimally invasive techniques are used; the lower price reflects exchange rates and lower operating costs, not a lower standard. For many couples watching both the calendar and their savings, the practical gains are shorter waiting times and seeing one responsible surgeon throughout.
| Factor | Your home country | Türkiye |
|---|---|---|
| Quality / standard | Very high | Very high |
| Typical waiting time | Often weeks to months | Often short |
| Single-surgeon continuity | Variable | One responsible surgeon |
| Out-of-pocket cost | Higher | Lower |
What if you need follow-up once you're back home?
Serious problems after a minor fertility procedure or laparoscopic surgery are rare, and we plan from the outset for the reassurance of staying reachable wherever you are. Complications are uncommon, generally affecting well under 1-2 % of patients, and most are minor — but if something does concern you after you return home, we remain contactable and coordinate directly with your local doctor and IVF clinic. Any assessment, surgical report and findings are prepared in a format your own team can use immediately, so nothing has to be repeated unnecessarily. We would far rather hear from you over a small worry than have you wait.
Getting a second opinion before you pay for add-ons
A second opinion is often worth far more than the small effort it takes, especially when you have been offered a list of paid extras or are facing another IVF cycle after a failed one. When you share your prior cycles, hormone results and imaging, we review whether a treatable condition was missed and give an honest view on which add-ons, if any, are reasonable in your situation. These consultations run as a paid, non-binding online second opinion and do not replace an in-person examination. You can start the first contact easily through a form or WhatsApp.
Frequently Asked Questions
Most add-ons are considered safe, but safe is not the same as effective. The main risk for many is spending extra money and hope on something that has little or no evidence of improving your chance of a baby.
Time-lapse imaging is rated as having no good evidence that it improves live birth rates compared with standard incubation. If it is offered free as part of standard care that is reasonable, but paying a significant extra fee is hard to justify on current evidence.
Because the chance of chromosomally abnormal embryos rises with age, PGT-A may reduce miscarriage and shorten time to pregnancy in some older women, but current evidence does not show it increases the overall chance of a baby for most patients. It is a decision to make case by case, not a routine extra.
No. No add-on can guarantee a pregnancy, and any clinic promising guaranteed success should be treated with caution. Honest guidance is about improving the odds where evidence supports it, not making promises.
In the regulator's rating system, red means there is no evidence the add-on is effective and a possible safety concern, while black means there is no evidence of benefit at all. These ratings are a useful warning sign before you pay for an extra.
The evidence for endometrial scratch is mixed and it has not shown a clear benefit for most patients. It may be considered in selected cases of repeated implantation failure, but it should be a discussion rather than an automatic step.
Immune tests and treatments such as intralipids, intravenous immunoglobulin and steroids are largely rated as having no evidence of benefit and some carry real risks. We do not recommend them outside a properly justified, individual situation.
After a minor office procedure such as an endometrial scratch, flying the same or next day is usually fine. After a hysteroscopy or laparoscopy, most patients are advised to wait around 7-10 days; staying mobile and hydrated during the flight lowers clot risk, and your surgeon confirms the timing.
Yes. We regularly review prior IVF cycles, hormone results and imaging as a paid, non-binding second opinion, and give an honest view on which add-ons, if any, are reasonable in your situation and whether a treatable condition was missed.
Often, yes. Correcting a condition that genuinely lowers IVF success, such as a hydrosalpinx, a submucosal fibroid or significant endometriosis, can improve your chances more than most laboratory add-ons. This is why we assess the body first.
It varies by clinic. Many add-ons are charged separately on top of the standard IVF fee, which is one reason to ask for a clear written breakdown and to question any extra that lacks good evidence.
Yes. Any assessment, surgical report and findings are prepared in a format your own IVF clinic and doctor can use immediately, and follow-up can continue remotely after you return home.
Planning your treatment from abroad
For international patients, the most efficient path is to begin with a digital assessment and reserve the visit to Türkiye for the steps where it matters most. You first share your imaging and IVF history and discuss the plan and an approximate cost in an online pre-consultation. When a procedure is planned, a stay of about 5-7 days is usually enough to cover assessment, the procedure and a first check. Flying is generally possible the same day after a minor office procedure, or around 7-10 days after laparoscopic surgery, on your surgeon's confirmation.
